NCT05450237
Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 2 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Notable Primary completion date: May 18, 2022 to Jul 1, 2025
- Start date: May 18, 2022 to Jul 1, 2022
- Study completion date: Jun 1, 2025 to Jun 1, 2026
- Study title shortened, about 1 word
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
500 patients will be enrolled in the study. The aim is to monitor over time items such as lifestyle indicators, cognitive, functional, emotional abilities and anxiety in patients with various types of neurological damage through use of evaluation scales.
Timeframe: These scales will be administered after certain time intervals. The results obtained will be compared in other to highlight a variation in the scores in the various items.The duration of administration of the scales is approximately one hour.
Arms and interventions
Behavioral: Psychometric Evaluations
Sites
1 site in 1 country
- Ircss NeuromedPozzilli, Isernia, Italy